Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

TGA Approval

GENRX IRINOTECAN irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial (246735)

ARTG ID

246735

ARTG Name

GENRX IRINOTECAN irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial

Sponsor

Baxter Healthcare Pty Ltd

ARTG Date

May 23, 2016

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Baxter Healthcare Pty Ltd

Sponsor Item Name

BAXTER HEALTHCARE PTY LTD

Active Ingredients

Ingredient Name

irinotecan hydrochloride trihydrate

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy